Paper2407050
Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study.
Tsementzis SA and 2 others. Acta Neurochir (Wien), 1990. Cited by 66 papers, by iCite.
Cite this record
ConductScience Library. Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study. Papers, record 2407050. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2407050
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclohexanecarboxylic Acids | Major topic |
| Subarachnoid Hemorrhage | Major topic |
| Tranexamic Acid | Major topic |
| Adult | |
| Aged | |
| Brain Ischemia | |
| Cerebrovascular Circulation | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Hydrocephalus | |
| Intracranial Aneurysm | |
| Male | |
| Middle Aged | |
| Postoperative Complications | |
| Prognosis | |
| Recurrence | |
| Rupture, Spontaneous |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 436386 | Acute delirious state after epsilon-amino caproic acid administration. | Clin Toxicol | 1979 | https://conductscience.org/library/papers/436386 | PubMed |
| 2 | 7010203 | Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial. | Neurosurgery | 1981 | https://conductscience.org/library/papers/7010203 | PubMed |
| 3 | 4138300 | Letter: Epsilon-aminocaproic acid and subarachnoid haemorrhage.?211. | Lancet | 1974 | https://conductscience.org/library/papers/4138300 | PubMed |
| 4 | 5790480 | The use of antifibrinolytic substances in ruptured intracranial aneurysms. | Neurochirurgia (Stuttg) | 1969 | https://conductscience.org/library/papers/5790480 | PubMed |
| 5 | 7376944 | Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid. | Acta Neurochir (Wien) | 1980 | https://conductscience.org/library/papers/7376944 | PubMed |
| 6 | 505491 | Tranexamic acid in subarachnoid hemorrhage. A double-blind study. | Stroke | 1979 | https://conductscience.org/library/papers/505491 | PubMed |
| 7 | 4830928 | Earlier operation and antifibrinolytic therapy in the management of aneurysmal subarachnoid haemorrhage. Review of recent experience in Tasmania. | Med J Aust | 1974 | https://conductscience.org/library/papers/4830928 | PubMed |
| 8 | 346153 | Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms? | Br Med J | 1978 | https://conductscience.org/library/papers/346153 | PubMed |
| 9 | 5041103 | The effect of the fibrinolytic inhibitor epsilon-aminocaproic acid on the incidence of deep-vein thrombosis after prostatectomy. | Br J Surg | 1972 | https://conductscience.org/library/papers/5041103 | PubMed |
| 10 | 85988 | Prevention of early recurrence of spontaneous subarachnoid haemorrhage by epsilon-aminocaproic acid. | Lancet | 1979 | https://conductscience.org/library/papers/85988 | PubMed |
| 11 | 81287 | Antifibrinolytic therapy of subarachnoid hemorrhage by intrathecal administration of p-aminomethylbenzoic acid. | J Neurol | 1978 | https://conductscience.org/library/papers/81287 | PubMed |
| 12 | 5639737 | Antifibrinolytic therapy for intracranial aneurysms. | J Neurosurg | 1968 | https://conductscience.org/library/papers/5639737 | PubMed |
| 13 | 4784923 | The use of antifibrinolytic agents in the preoperative treatment of ruptured intracranial aneurysms. | Trans Am Neurol Assoc | 1973 | https://conductscience.org/library/papers/4784923 | PubMed |
| 14 | 1198627 | Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage. | Stroke | 1975 | https://conductscience.org/library/papers/1198627 | PubMed |
| 15 | 5576488 | Use of an anti-fibrinolytic agent (tranexamic acid) in the management of ruptured intracranial aneurysms. | Postgrad Med J | 1971 | https://conductscience.org/library/papers/5576488 | PubMed |
| 16 | 365072 | Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial. | Ann Neurol | 1977 | https://conductscience.org/library/papers/365072 | PubMed |
| 17 | 6402715 | Progressive change in cerebral blood flow during the first three weeks after subarachnoid hemorrhage. | Neurosurgery | 1983 | https://conductscience.org/library/papers/6402715 | PubMed |
| 18 | 354483 | Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial. | Ann Neurol | 1978 | https://conductscience.org/library/papers/354483 | PubMed |
| 19 | 6166061 | The role of antifibrinolytic therapy in the preoperative management of recently ruptured intracranial aneurysms. | Surg Neurol | 1981 | https://conductscience.org/library/papers/6166061 | PubMed |
| 20 | 6179402 | Antifibrinolytics in aneurysmal subarachnoid haemorrhage. A retrospective comparison of two different forms of antifibrinolytic therapy. | Acta Neurochir (Wien) | 1982 | https://conductscience.org/library/papers/6179402 | PubMed |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42616160 | Tranexamic acid after aneurysmal subarachnoid hemorrhage is associated with worse outcome in males: post hoc analysis of the ULTRA trial. | J Neurol | 2026 | https://conductscience.org/library/papers/42616160 | PubMed |
| 42568002 | Impact of tranexamic acid on outcomes in early-admitted patients with aneurysmal subarachnoid hemorrhage: a systematic review and bayesian meta-analysis of randomized controlled trials. | J Thromb Thrombolysis | 2026 | https://conductscience.org/library/papers/42568002 | PubMed |
| 42095754 | European Stroke Organisation (ESO), European Association of Neurosurgical Societies (EANS) and European Society for Minimally Invasive Neurological Therapy (ESMINT) guideline on aneurysmal subarachnoid haemorrhage. | Eur Stroke J | 2026 | https://conductscience.org/library/papers/42095754 | PubMed |
| 41134732 | Sex Disparities in Intracranial Aneurysm Trial Participation: A Systematic Review and Meta-Analysis. | Cerebrovasc Dis | 2026 | https://conductscience.org/library/papers/41134732 | PubMed |
| 40599738 | Efficacy and safety of tranexamic acid administration for subarachnoid hemorrhage: a systematic review and meta-analysis. | Front Neurol | 2025 | https://conductscience.org/library/papers/40599738 | PubMed |
| 40316838 | Relationship between Tranexamic Acid Use and Safety in Patients with Acute Brain Injury: A Systematic Review and Meta-analysis of Mortality and Thromboembolic Events. | CNS Drugs | 2025 | https://conductscience.org/library/papers/40316838 | PubMed |
| 39564438 | The efficacy and application of tranexamic acid in emergency medicine: Emergency Medicine Association of Türkiye clinical policy- 2024. | Turk J Emerg Med | 2024 | https://conductscience.org/library/papers/39564438 | PubMed |
| 37228855 | The efficacy of antifibrinolytic therapy in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. | Future Sci OA | 2023 | https://conductscience.org/library/papers/37228855 | PubMed |
| 37202712 | Guidelines for the Neurocritical Care Management of Aneurysmal Subarachnoid Hemorrhage. | Neurocrit Care | 2023 | https://conductscience.org/library/papers/37202712 | PubMed |
| 37000863 | Efficacy and safety of tranexamic acid in intracranial haemorrhage: A meta-analysis. | PLoS One | 2023 | https://conductscience.org/library/papers/37000863 | PubMed |
| 36350005 | Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. | Cochrane Database Syst Rev | 2022 | https://conductscience.org/library/papers/36350005 | PubMed |
| 35140671 | Safety and Efficacy of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials. | Front Neurol | 2021 | https://conductscience.org/library/papers/35140671 | PubMed |
| 35083272 | Efficacy and Safety of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | Front Surg | 2021 | https://conductscience.org/library/papers/35083272 | PubMed |
| 34677620 | Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine. | Intensive Care Med | 2021 | https://conductscience.org/library/papers/34677620 | PubMed |
| 34315966 | Tranexamic acid in non-traumatic intracranial bleeding: a systematic review and meta-analysis. | Sci Rep | 2021 | https://conductscience.org/library/papers/34315966 | PubMed |
| 34221603 | Effect of tranexamic acid on blood loss, coagulation profile, and quality of surgical field in intracranial meningioma resection: A prospective randomized, double-blind, placebo-controlled study. | Surg Neurol Int | 2021 | https://conductscience.org/library/papers/34221603 | PubMed |
| 33851983 | Association of Intravenous Tranexamic Acid With Thromboembolic Events and Mortality: A Systematic Review, Meta-analysis, and Meta-regression. | JAMA Surg | 2021 | https://conductscience.org/library/papers/33851983 | PubMed |
| 30741383 | Tranexamic Acid in Cerebral Hemorrhage: A Meta-Analysis and Systematic Review. | CNS Drugs | 2019 | https://conductscience.org/library/papers/30741383 | PubMed |
| 28261426 | Is Intraoperative Use of QuikClot Combat Gauze Effective for Hemostasis after Total Knee Arthroplasty? | Clin Orthop Surg | 2017 | https://conductscience.org/library/papers/28261426 | PubMed |
| 26937276 | Advances in the understanding of delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage. | F1000Res | 2015 | https://conductscience.org/library/papers/26937276 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2407050
GET https://conductscience.org/api/papers/v1/2407050/references?page=2